Treatment of Acute Cholecystitis
Early laparoscopic cholecystectomy within 7-10 days of symptom onset is the definitive treatment for acute cholecystitis, combined with immediate empirical antibiotics tailored to disease severity and patient risk factors. 1, 2, 3
Initial Diagnostic Approach
Obtain ultrasound as first-line imaging to identify gallbladder wall thickening (>3mm), pericholecystic fluid, gallstones impacted in the cystic duct, and elicit sonographic Murphy's sign. 1, 3 CT with IV contrast or MRCP can be added if ultrasound is inconclusive or if common bile duct stones are suspected. 1
Check white blood cell count and inflammatory markers (CRP), though acute cholecystitis can present without leukocytosis or fever—absence of these findings does not exclude the diagnosis. 3, 4
Immediate Medical Management
Start empirical antibiotics promptly upon diagnosis, before surgical intervention. 3, 5 Initiate IV hydration, maintain NPO status, and provide analgesia as needed. 6, 7
Antibiotic Selection Algorithm
For Uncomplicated Cholecystitis in Stable, Immunocompetent Patients:
First-line: Amoxicillin/Clavulanate 2g/0.2g IV every 8 hours. 1, 3, 5
Alternatives: Ceftriaxone plus Metronidazole, or Ticarcillin/Clavulanate. 3, 5
For documented beta-lactam allergy: Eravacycline 1 mg/kg IV every 12 hours or Tigecycline 100 mg loading dose then 50 mg IV every 12 hours. 1
For Complicated Cholecystitis or Critically Ill/Immunocompromised Patients:
First-line: Piperacillin/Tazobactam 4g/0.5g IV every 6 hours (or 16g/2g by continuous infusion). 1, 3, 5, 8
For patients with inadequate/delayed source control or high risk of ESBL-producing Enterobacterales: Ertapenem 1g IV every 24 hours or Eravacycline 1 mg/kg IV every 12 hours. 1, 5
For septic shock: Meropenem 1g IV every 6 hours by extended infusion, Doripenem 500 mg IV every 8 hours by extended infusion, Imipenem/cilastatin 500 mg IV every 6 hours by extended infusion, or Eravacycline 1 mg/kg IV every 12 hours. 1
Important Coverage Considerations:
Anaerobic coverage is already included in the recommended regimens and is appropriate for biliary infections. 5, 8 Add enterococcal coverage only for healthcare-associated infections. 5, 8 Add vancomycin for MRSA coverage only in healthcare-associated infections with known colonization or prior treatment failure. 5, 8
Surgical Management Strategy
Uncomplicated Acute Cholecystitis:
For Class A or B patients (stable, no organ dysfunction): Perform urgent cholecystectomy with one-shot antibiotic prophylaxis and no postoperative antibiotics. 2, 3, 5
For Class C patients (critically ill with organ dysfunction): Perform emergent/urgent cholecystectomy with postoperative antibiotic therapy. 2
Complicated Acute Cholecystitis:
For Class A or B patients: Perform urgent cholecystectomy with short-course postoperative antibiotics for 1-4 days. 2, 3
For Class C patients fit for surgery: Perform emergent cholecystectomy with postoperative antibiotic therapy duration up to 7 days based on clinical conditions and inflammatory markers. 1, 2
Laparoscopic approach is preferred over open cholecystectomy due to shorter hospital stay, less pain, and faster recovery. 9, 6, 7
Alternative Management for High-Risk Patients
Percutaneous cholecystostomy is indicated for: critically ill patients with multiple comorbidities unfit for surgery, or patients failing to improve after 3-5 days of antibiotic therapy alone. 2, 8 This serves as a temporizing "bridge" measure until definitive surgery can be performed. 5
Important caveat: Cholecystostomy is inferior to cholecystectomy in terms of major complications for critically ill patients when surgery is feasible. 1
Antibiotic Duration Guidelines
Uncomplicated cholecystitis with early surgery (within 7-10 days): One-shot prophylaxis only, no postoperative antibiotics. 1, 3, 5, 10
Complicated cholecystitis with adequate source control in immunocompetent, non-critically ill patients: 4 days of antibiotics. 1, 3, 5, 8
Complicated cholecystitis with adequate source control in immunocompromised or critically ill patients: Up to 7 days based on clinical response and inflammatory markers. 1, 3, 8
Discontinue antibiotics within 24 hours after cholecystectomy if adequate source control was achieved and infection was confined to the gallbladder wall. 5, 10
Patients with ongoing signs of infection beyond 7 days warrant diagnostic investigation for inadequate source control or alternative diagnoses. 1
Critical Pitfalls to Avoid
Do not delay surgery beyond 7-10 days from symptom onset in patients fit for surgery—approximately 30% of conservatively treated patients develop recurrent complications and 60% ultimately require cholecystectomy. 5
Do not continue broad-spectrum antibiotics unnecessarily after adequate source control to prevent antibiotic resistance. 2, 8
Do not use ciprofloxacin plus metronidazole as first-line therapy in critically ill or immunocompromised patients—this combination lacks sufficient coverage for severe disease. 5
Obtain bile cultures in complicated cases to guide targeted antibiotic therapy, especially in healthcare-associated infections. 8, 11
Special Populations
Elderly patients require early correct empirical therapy as it significantly impacts outcomes. 3
Emphysematous cholecystitis requires emergency cholecystectomy with immediate broad-spectrum antibiotics. 3
Acalculous cholecystitis in critically ill patients: Percutaneous cholecystostomy is the preferred initial intervention combined with piperacillin/tazobactam, reserving cholecystectomy only for patients who can tolerate surgery. 8
Multidisciplinary Management
Complex and severe cases should be managed with multidisciplinary teams including surgeons, anesthesiologists, and infectious disease specialists, particularly for antibiotic stewardship decisions. 2, 8